Psychedelic Mushrooms Could Change The Way Cancer Patients Deal With Anxiety

With medical marijuana now legalized in 28 states and the District of Columbia, the debate over when, and if, a previously illegal and often stigmatized drug should be used to treat serious symptoms will likely carry on through the foreseeable future. However, new research shows that another illegal, and far more psychedelic, substance may also have certain health advantages as well.
According to the results of two studies released last year, psilocybin, the active ingredient in magic mushrooms, can help ease feelings of anxiety and depression in cancer patients.
In both studies, one conducted at NYU and the other at Johns Hopkins University, 80 percent of cancer patients reported a decrease in anxiety and depression for at least six months. Psychiatric evaluators also supported their patients’ claims, noting an increase in optimism as well as overall quality of life. In the NYU-led research, 70 percent of participants said taking psilocybin was one of the five most important experiences they’d ever had.